Literature DB >> 16554447

Race and ethnicity in the era of emerging pharmacogenomics.

Lea Harty1, Keith Johnson, Aidan Power.   

Abstract

Race and ethnicity are terms that are commonly used to categorize subjects in medical research. Advances in genetics and the emerging discipline of pharmacogenomics have brought these terms under scrutiny, with arguments either for the continued use or for the abandonment of these terms generating strong views. As pharmacogenomics research develops, we may find that more accurate and specific descriptions of relevant variation in genes will reduce the value that these imprecise descriptors have in predicting how people will respond to drug therapies.

Entities:  

Mesh:

Year:  2006        PMID: 16554447     DOI: 10.1177/0091270005286028

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  8 in total

1.  Ethical issues in pediatric pharmacogenomics.

Authors:  Kyle B Brothers
Journal:  J Pediatr Pharmacol Ther       Date:  2013-07

Review 2.  Pharmacology behind Common Drug Nephrotoxicities.

Authors:  Mark A Perazella
Journal:  Clin J Am Soc Nephrol       Date:  2018-04-05       Impact factor: 8.237

3.  CYP2D6 and CYP2C19 in Papua New Guinea: High frequency of previously uncharacterized CYP2D6 alleles and heterozygote excess.

Authors:  Nicolas von Ahsen; Mladen Tzvetkov; Harin A Karunajeewa; Servina Gomorrai; Alice Ura; Jürgen Brockmöller; Timothy M E Davis; Ivo Mueller; Kenneth F Ilett; Michael Oellerich
Journal:  Int J Mol Epidemiol Genet       Date:  2010-08-18

4.  Community-based dialogue: engaging communities of color in the United states' genetics policy conversation.

Authors:  Vence L Bonham; Toby Citrin; Stephen M Modell; Tené Hamilton Franklin; Esther W B Bleicher; Leonard M Fleck
Journal:  J Health Polit Policy Law       Date:  2009-06       Impact factor: 2.265

5.  Risk, reward, and the double-edged sword: perspectives on pharmacogenetic research and clinical testing among Alaska Native people.

Authors:  Jennifer L Shaw; Renee Robinson; Helene Starks; Wylie Burke; Denise A Dillard
Journal:  Am J Public Health       Date:  2013-10-17       Impact factor: 9.308

Review 6.  Nephrotoxicity of recent anti-cancer agents.

Authors:  Norbert Lameire
Journal:  Clin Kidney J       Date:  2013-11-26

7.  The potential risk factors of nephrotoxicity during vancomycin therapy in Chinese adult patients.

Authors:  Yulin Wang; Jian Yang; Haiyan Zhan; Shuxiao Zhang; Yin Deng
Journal:  Eur J Hosp Pharm       Date:  2020-06-10

8.  Occupational exposure to polychlorinated biphenyls and risk of breast cancer.

Authors:  Sharon R Silver; Elizabeth A Whelan; James A Deddens; N Kyle Steenland; Nancy B Hopf; Martha A Waters; Avima M Ruder; Mary M Prince; Lee C Yong; Misty J Hein; Elizabeth M Ward
Journal:  Environ Health Perspect       Date:  2008-09-26       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.